Ledger.Open graph →
SEC Form D · filed August 13, 2014

BRICKELL BIOTECH, INC

Offering
$3.0M
Sold
$2.2M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
MIAMI, FL
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (14)

Bruno S. Maruzzo · LONDON, Ontario, CanadaExecDouglas S. Alexander · LONDON, Ontario, CanadaExecDavid E. Cohen · Miami, FLDirectorBruce Morgan · Alamo, CAExecGene Kelly · LONDON, Ontario, CanadaExec · DirectorDavid S. Sanderson · LONDON, Ontario, CanadaExec · DirectorWayne R. Danter · LONDON, Ontario, CanadaExec · DirectorJohn C. Drake · LONDON, Ontario, CanadaExec · DirectorAndrea J. Knight · Bainbridge Island, WAExec · DirectorMarsha G. Folsom · Cullman, ALExec · DirectorDavid M. Knight · Bainbridge Island, WAExecJonathan M. Scherch · Seattle, WAExecLawrence Lepard · Wellesley, MADirectorMichael A. Snetzer · Lebanon, NHDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗